Detalhe da pesquisa
1.
Proteomic investigations into hypertension: what's new and how might it affect clinical practice?
Expert Rev Proteomics
; 16(7): 583-591, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195841
2.
Estimating the impact of obesity and metabolic phenotype on sickness absence. Results from the ICARIA study.
Nutr Metab Cardiovasc Dis
; 29(4): 383-389, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803866
3.
Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.
Biomed Pharmacother
; 168: 115661, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832406
4.
[2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension]. / Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA).
Hipertens Riesgo Vasc
; 39(4): 174-194, 2022.
Artigo
em Espanhol
| MEDLINE | ID: mdl-36153303
5.
A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
Blood Press
; 20(6): 322-34, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21936729
6.
[Awareness, treatment and control of blood pressure according to place of recruitment and sex in the May Measure Month 2018 survey in Spain]. / Conocimiento, tratamiento y control de la presión arterial según lugar de reclutamiento y sexo en la encuesta May Measure Month 2018 en España.
Hipertens Riesgo Vasc
; 38(1): 4-12, 2021.
Artigo
em Espanhol
| MEDLINE | ID: mdl-32807680
7.
2021 Spanish Society of Hypertension position statement about telemedicine.
Hipertens Riesgo Vasc
; 38(4): 186-196, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888438
8.
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Diabetologia
; 53(1): 49-57, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19876613
9.
Management of hypertension in the very old: aggressive reduction of blood pressure is harmful in most patients.
J Hum Hypertens
; 34(8): 557-559, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376997
10.
[Position statement on ambulatory blood pressure monitoring (ABPM) by the Spanish Society of Hypertension (2019)]. / Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre monitorización ambulatoria de la presión arterial (MAPA) 2019.
Hipertens Riesgo Vasc
; 36(4): 199-212, 2019.
Artigo
em Espanhol
| MEDLINE | ID: mdl-31178410
11.
Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration.
Hipertens Riesgo Vasc
; 40(2): 55-57, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529615
12.
Microvascular injury and the kidney in hypertension.
Hipertens Riesgo Vasc
; 35(1): 24-29, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28431922
13.
Oral health, hypertension and cardiovascular diseases.
Hipertens Riesgo Vasc
; 40(4): 167-170, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173185
14.
Obesity and hypertension in Latin America: Current perspectives.
Hipertens Riesgo Vasc
; 35(2): 70-76, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361428
15.
[Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines]. / Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial.
Hipertens Riesgo Vasc
; 2018 Apr 24.
Artigo
em Espanhol
| MEDLINE | ID: mdl-29699926
16.
Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.
J Hum Hypertens
; 21(6): 479-85, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17314997
17.
Hypertension in Latin America: Current perspectives on trends and characteristics.
Hipertens Riesgo Vasc
; 34(1): 50-56, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28007488
18.
Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
Transplant Proc
; 38(8): 2419-23, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17097955
19.
[Benefits of spironolactone as the optimal treatment for drug resistant hypertension. Pathway-2 trial review]. / Utilidad de la espironolactona en el manejo farmacológico de la hipertensión arterial resistente. Comentarios sobre el estudio Pathway-2.
Hipertens Riesgo Vasc
; 33(4): 150-154, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-27363610
20.
[Cardiovascular risk study in patients with renin-angiotensin system blockade by means of the proteone of circulating extracellular vesicles]. / Estudio del riesgo cardiovascular en pacientes con bloqueo del sistema renina-angiotensina a través del proteoma de las vesículas extracelulares circulantes.
Hipertens Riesgo Vasc
; 33(1): 21-7, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26826536